Progressive choroidal thinning (leptochoroid) and fundus depigmentation associated with checkpoint inhibitors.

Canestraro, Julia; Jaben, Korey A; Wolchok, Jedd D; Abramson, David H; Francis, Jasmine H.

Afiliação

Canestraro J; Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Jaben KA; Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Wolchok JD; Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Abramson DH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Francis JH; Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.

Am J Ophthalmol Case Rep ; 19: 100799, 2020 Sep.

Article em En | MEDLINE | ID: mdl-32637735